InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,467.78
(
-1.43%
)
Post# of 54865
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BooDog

Send PM Follow Ignore
Followers 230
Posts 21493
Boards Moderated 2
Alias Born 08/03/2006

BooDog

Re: None

Friday, 12/19/2014 2:17:43 PM

Friday, December 19, 2014 2:17:43 PM

Post# of 54865
AstraZeneca Gets FDA Approval for Ovarian Cancer DrugFriday 12/19/2014 01:15 PM ET - Dow Jones News
LONDON--Pharmaceutical company AstraZeneca PLC (AZN.LN) on Friday said the U.S. Food and Drug Administration has approved Lynparza for the treatment of advanced ovarian cancer. The regulator has approved 400 milligrams capsules of Lynparza as the first monotherapy for patients with advanced ovarian cancer, who have been treated with three or more prior lines of chemotherapy.


"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up